Stockscreener 앱 받기
2.08
3.48%
0.07
시간 외 거래:
2.08
전일 마감가:
$2.01
열려 있는:
$2.01
하루 거래량:
423.78K
Relative Volume:
0.29
시가총액:
$153.70M
수익:
$302.48M
순이익/손실:
$-265.26M
주가수익비율:
-0.5597
EPS:
-3.716
순현금흐름:
$-2.76M
1주 성능:
-7.56%
1개월 성능:
+20.93%
6개월 성능:
-7.56%
1년 성능:
-45.97%
1일 변동 폭
$2.01
$2.105
1주일 범위
$2.01
$2.25
52주 변동 폭
$0.9551
$4.115
Health Catalyst Inc Stock (HCAT) Company Profile
명칭
Health Catalyst Inc
전화
801-708-6800
주소
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, BTSG, HQY, TEM, TXG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
2.08 | 153.70M | 302.48M | -265.26M | -2.76M | -3.716 |
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-18 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-08-27 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-08-08 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2025-01-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2024-01-03 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-13 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-11-13 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-05-10 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-05-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | 개시 | Stephens | Equal-Weight |
| 2023-04-04 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-10-31 | 개시 | Wells Fargo | Equal Weight |
| 2022-10-25 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-08-05 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-03-17 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-10-14 | 개시 | BTIG Research | Buy |
| 2021-04-29 | 재개 | JP Morgan | Overweight |
| 2020-12-08 | 개시 | Berenberg | Buy |
| 2020-07-14 | 개시 | Citigroup | Buy |
| 2020-06-18 | 개시 | Stifel | Buy |
| 2020-06-15 | 재개 | Evercore ISI | Outperform |
| 2020-05-15 | 개시 | Guggenheim | Buy |
| 2020-04-21 | 개시 | RBC Capital Mkts | Outperform |
| 2020-04-13 | 개시 | SVB Leerink | Outperform |
| 2020-04-02 | 개시 | Canaccord Genuity | Buy |
| 2019-12-20 | 개시 | Raymond James | Strong Buy |
| 2019-10-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-08-19 | 개시 | Evercore ISI | Outperform |
| 2019-08-19 | 개시 | Goldman | Buy |
| 2019-08-19 | 개시 | JP Morgan | Overweight |
| 2019-08-19 | 개시 | Piper Jaffray | Overweight |
| 2019-08-19 | 개시 | SVB Leerink | Outperform |
| 2019-08-19 | 개시 | SunTrust | Buy |
| 2019-08-19 | 개시 | William Blair | Outperform |
모두보기
Health Catalyst Inc 주식(HCAT)의 최신 뉴스
Health Catalyst, Inc. Revenue Breakdown – LSX:A2PH3J - TradingView
HCAT|Health Catalyst Inc|Price:2.080|Chg%:+0.070 - TradingKey
HCAT|Health Catalyst Inc|Price:2.025|Chg%:+0.015 - TradingKey
Health Catalyst Inc (HCAT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Impax Asset Management Group (HCAT) discloses 4M-share position in Health Catalyst - Stock Titan
HCAT Maintained by Canaccord Genuity -- Price Target Raised to $3.00 - GuruFocus
Health Catalyst (HCAT) awards 80,691 restricted stock units to company director - Stock Titan
Health Catalyst Declares Voting Results - marketscreener.com
Health Catalyst shareholders rejected charter restatement to phase out classified board structure - Bitget
Health Catalyst (NASDAQ: HCAT) holders back pay, auditor and retain classified board - Stock Titan
Health Catalyst, Commerce, and Paycom Shares Plummet, What You Need To Know - Yahoo Finance
Health Catalyst Investors Approve Directors, Pay; Board Declassification Fails - MarketBeat
Health Catalyst (HCAT) AGM 2026 Summary - Quartr
Health Catalyst Inc Annual Shareholders Meeting Transcript - GuruFocus
Health Catalyst investors approve directors, pay; board declassification fails - MSN
3 Reasons to Sell HCAT and 1 Stock to Buy Instead - Yahoo Finance
Health Catalyst (HCAT) Edges Higher at $2.29 – Can Resistance at $2.40 Be Broken?MACD Signal Stocks - dars.gov.et
HCAT Q1 2026 Earnings: EPS Beats Estimates by 14.3%, Shares Edge HigherDividend Increase Stocks - dars.gov.et
monday.com, Intuit, and Health Catalyst Stocks Trade Down, What You Need To Know - Yahoo Finance
Health Catalyst(HCAT) Stock Options Chain | Quotes & News - Moomoo
Price to earnings forward of Health Catalyst, Inc – NASDAQ:HCAT - TradingView
Price to sales forward of Health Catalyst, Inc – NASDAQ:HCAT - TradingView
Price to sales forward of Health Catalyst, Inc. – LS:A2PH3J - TradingView
Health Catalyst Company Profile & Introduction - Moomoo
Discover Health Catalyst And 2 More Promising Penny Stocks - simplywall.st
Enterprise value to EBITDA forward of Health Catalyst, Inc – NASDAQ:HCAT - TradingView
A Quick Look at Today's Ratings for Health Catalyst(HCAT.US), With a Forecast Between $1.75 to $2 - Moomoo
Health Catalyst, PubMatic, and PTC Stocks Trade Up, What You Need To Know - Yahoo Finance
HCATHealth Catalyst Inc Options - Finviz
Health Catalyst, Inc.(NasdaqGS: HCAT) dropped from Russell 2000 Index - marketscreener.com
Health Catalyst, Inc.(NasdaqGS: HCAT) dropped from Russell 2000 Value Benchmark - marketscreener.com
Health Catalyst, Inc.(NasdaqGS: HCAT) dropped from Russell 3000E Index - marketscreener.com
Health Catalyst, Inc.(NasdaqGS:HCAT) dropped from Russell Small Cap Completeness Index - marketscreener.com
Health Catalyst (HCAT) Surges 7.3% as Positive Momentum Builds Above Key SupportOn Balance Volume - dars.gov.et
Health Catalyst Inc (HCAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
HCAT Maintained by Wells Fargo -- Price Target Raised to $1.75 - GuruFocus
Health Catalyst Inc (HCAT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
What's Driving the Recent Buzz Around Health Catalyst (HCAT) and ZoomInfo (ZI) Stocks - Kavout | AI
Data Analytics Stocks Q1 Highlights: Health Catalyst (NASDAQ:HCAT) - Yahoo Finance
Health Catalyst, Zoom, and Autodesk Shares Are Falling, What You Need To Know - Yahoo Finance
Ryan L. Vardeman discloses investment at Health Catalyst with 6.7% stake - TradingView
Palogic reports 6.7% Health Catalyst (HCAT) stake and outlines possible actions - Stock Titan
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains? - Yahoo Finance
Health Catalyst Inc (HCAT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Health Catalyst Inc (HCAT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Health Catalyst Inc (HCAT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Health Catalyst Inc (HCAT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Health Catalyst Inc (HCAT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Health Catalyst Inc (HCAT) Institutional Confidence - TradingKey
Health Catalyst to Participate in Upcoming Investor Conference - The Manila Times
Health Catalyst and Paycom shares are falling, what you need to know - MSN
Health Catalyst Inc (HCAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.99%
2.12%
자본화:
|
볼륨(24시간):